Minimally Invasive Procedure Seeks and Destroys Cancer Cells, Sparing Healthy Tissue


Vol. 15, No. 1
Summer 2005

  • CyberKnife at Winthrop Revolutionizes Cancer Care

  • Stroke Center Receives NYS Department of Health's Stamp of Approval

  • New Corkscrew Device Saves Stroke Patients' Lives

  • Minimally Invasive Procedure Seeks and Destroys Cancer Cells, Sparing Healthy Tissue

  • Early Detection and Flexible Treatment Get Player Back in the Game

  • Winthrop Performs Unusual Heart Operation

  • McCann Endoscopy Center Opens

  • Winthrop is First to Offer New Treatment for Female Urinary Incontinence

  • 'Dining Out' Series Teaches Healthful Choices

  • Asian Flare Sets the Stage for 2005 Gala

  • Comprehensive Class Alleviates Anxieties of Patients Facing Hip or Knee Replacement Surgery

  • Andy Foundation's NFL Day Benefits Cancer Center for Kids

  • Get a Jump on Your Holiday Shopping While Helping Young Patients

  • Jets All-Pro Center Teams Up with Winthrop for Second Annual Challenge Benefiting Young Patients

  • Creative Cards Benefit Cancer Center for Kids

  • Starlight Starbright Foundation Tours Peds Inpatient Center

  • Reach Out and Read Program Receives Generous Support

  • The Future: Your Legacy

  • Great Neck 5K

  • Winthrop Wins Grant to 'Reinvent the House Call'

  • Team Winthrop Rallies to Support Hurricane Relief Efforts

    Back to Publications

  • Diagnosed with lung cancer five years ago, Joseph Palagonia relied on chemotherapy until his physician recommended another option: a relatively new, minimally invasive procedure that would shrink the tumor on his left lung. Paired with chemotherapy treatments, radiofrequency ablation (RFA) packed a powerful punch against his cancer.


    L-R: Man Hon, MD, Chief of Vascular and Interventional Radiology, and Carole Cecchino, RN, MPA/HAD, Nurse Manager, Radiology, prepare for a radiofrequency ablation procedure.
    In the spring of 2004, Mr. Palagonia came to Winthrop-University Hospital's Lung Cancer Center with the hope that RFA would improve his condition. It did.

    RFA involves the placement of a needle probe (electrode) within the tumor. Generating heat via an electrical current, the probe destroys tumor cells.

    "Technically, RFA is similar to percutaneous biopsies (performed through the skin), which Winthrop has expertly performed for years," explained Man Hon, MD, Winthrop's Chief of Vascular and Interventional Radiology.

    RFA is considered for those living with liver tumors, metastatic colon cancer, lung and kidney masses and bone metastases.

    After evaluating the lesion size and location, interventional radiologists work closely with oncologists and surgeons to determine if RFA is appropriate for the patient.

    "Generally, lesions less than three centimeters, which is a little more than an inch, are considered ideal for treatment and have a high success rate," Dr. Hon explained.

    If RFA is an option, physicians use CT scans, ultrasound or fluoroscopy to guide the placement of the electrode in an optimal position inside the tumor.

    The current is turned on, sparing healthy tissue surrounding the targeted area.

    "It was very simple and I felt nothing during the process," Mr. Palagonia explained.

    RFA Advantages
  • Found to be well-tolerated by patients.
  • Can be performed with an overnight admission, or, in certain cases, as an outpatient procedure.
  • Most patients may resume normal routines the next day.
  • Rarely need general anesthesia.
  • Conscious sedation or deep sedation can be used.
  • Only tumor tissue is treated.
  • Can be repeated multiple times as new lesions are found.
  • Can relieve pain for many cancer patients.
  • A year after receiving RFA, PET and CAT scans of Mr. Palagonia's lung have shown no signs of recurrence and most importantly—he feels great.

    "Everything's beautiful, everything's stabilized," he said. "My doctor even told me ‘take a break and don't come back for six weeks, there's no need'." Offering a comprehensive program of prevention and treatments for those diagnosed with lung cancer and people at risk of developing the disease, the Lung Cancer Center's multidisciplinary team understands the anxiety patients experience. Under the umbrella of Winthrop's Institute for Cancer Care, the Hospital's lung cancer specialists coordinate their efforts to meet the unique situations and needs of all patients and their families.

    To find out more about RFA, call (516) 663-2452. For information about the Lung Cancer Center, call (516) 663-4637.



    [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design